5.2. Nature de l'agent ,
2. Description de la population de patients ,
Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer, pp.358-63, 2000. ,
Identification of a Subgroup of Patients at Highest Risk for Complications After Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy, Annals of Surgery, vol.256, issue.2, pp.334-375, 2012. ,
DOI : 10.1097/SLA.0b013e31825704e3
Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, Surgery, vol.152, issue.4, pp.617-624, 2012. ,
DOI : 10.1016/j.surg.2012.07.027
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion, Cancer, vol.17, issue.5, pp.1144-53, 2006. ,
DOI : 10.1002/cncr.21708
Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy, Annals of Surgical Oncology, vol.106, issue.9, pp.2370-2377, 2010. ,
DOI : 10.1245/s10434-010-1039-7
DISTRIBUTION OF INTRA-ABDOMINAL MALIGNANT SEEDING: DEPENDENCY ON DYNAMICS OF FLOW OF ASCITIC FLUID, American Journal of Roentgenology, vol.119, issue.1, pp.198-206, 1973. ,
DOI : 10.2214/ajr.119.1.198
Malignant ascites, British Journal of Surgery, vol.71, issue.1, pp.6-14, 1996. ,
DOI : 10.1002/bjs.1800830104
Results of Treatment of 385 Patients With Peritoneal Surface Spread of Appendiceal Malignancy, Annals of Surgical Oncology, vol.6, issue.8, pp.727-758, 1999. ,
DOI : 10.1007/s10434-999-0727-7
Epidemiology of peritoneal mesothelioma: a review, Annals of Oncology, vol.18, issue.6, pp.985-90, 2007. ,
DOI : 10.1093/annonc/mdl345
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial, Annals of Surgical Oncology, vol.70, issue.Suppl, pp.1575-81, 2011. ,
DOI : 10.1245/s10434-011-1631-5
Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma, European Journal of Surgical Oncology (EJSO), vol.28, issue.1, 2002. ,
DOI : 10.1053/ejso.2001.1152
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis, Cancer Treat Res, vol.82, pp.359-74, 1996. ,
DOI : 10.1007/978-1-4613-1247-5_23
Rapport du 110e congrès français de chirurgie. Carcinomatoses péritonéales d'origine digestive et primi-tive. Monographie de l'Association Française de Chirurgie ,
Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res, pp.5790-5794, 1990. ,
Differential response of normal and tumor microcirculation to hyperthermia. Cancer Res, Feb, vol.44, issue.2, pp.605-617, 1984. ,
Hyperthermia and drugs. Recent Results Cancer Res Fortschritte Krebsforsch Progrès Dans Rech Sur Cancer, pp.136-203, 1987. ,
Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system, International Journal of Hyperthermia, vol.29, issue.2, pp.285-96, 1993. ,
DOI : 10.1126/science.145.3627.55
Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures]. Chir Mém Académie Chir, 1999. ,
Classification of Surgical Complications, Annals of Surgery, vol.240, issue.2, 2004. ,
DOI : 10.1097/01.sla.0000133083.54934.ae
Chimiothérapie hyperthermique intrapéritonéale : morbidité et mortalité postopératoire, 2009. ,
Oxaliplatin-related thrombocytopenia, Annals of Oncology, vol.23, issue.8, pp.1937-1979, 2012. ,
DOI : 10.1093/annonc/mds074
Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis, Journal of Surgical Oncology, vol.238, issue.4, pp.220-225, 2005. ,
DOI : 10.1002/jso.20253
A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C, Journal of Surgical Research, vol.179, issue.1, pp.133-139, 2013. ,
DOI : 10.1016/j.jss.2012.01.015
Complications and Toxicities After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, Annals of Surgical Oncology, vol.94, issue.11, pp.1082-1089 ,
DOI : 10.1245/s10434-012-2853-x
Human Pharmacokinetic Study of Heated Intraperitoneal Oxaliplatin in Increasingly Hypotonic Solutions after Complete Resection of Peritoneal Carcinomatosis, Oncology, vol.63, issue.4, pp.346-52, 2002. ,
DOI : 10.1159/000066229
Hemophagocytic Syndrome: An Unusual and Underestimated Complication of Cytoreduction Surgery with Heated Intraperitoneal Oxaliplatin, Annals of Surgical Oncology, vol.40, issue.12, pp.3919-3945, 2013. ,
DOI : 10.1245/s10434-013-3099-y
Anesthesia Considerations During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, Surgical Oncology Clinics of North America, vol.21, issue.4, pp.533-574 ,
DOI : 10.1016/j.soc.2012.07.003
Cardiovascular Changes During Continuous Hyperthermic Peritoneal Perfusion, Anesthesia & Analgesia, vol.78, issue.5, pp.938-980, 1994. ,
DOI : 10.1213/00000539-199405000-00018
Complications and death following anaesthesia. A prospective study with special reference to the influence of patient-, anaesthesia-, and surgery-related risk factors, Dan Med Bull, vol.41, issue.3, pp.319-350, 1994. ,
Prevention of postoperative pulmonary complications through respiratory rehabilitation: A controlled clinical study, Archives of Physical Medicine and Rehabilitation, vol.79, issue.1, pp.5-9, 1998. ,
DOI : 10.1016/S0003-9993(98)90198-8
Effects of Intravenous Fluid Restriction on Postoperative Complications: Comparison of Two Perioperative Fluid Regimens, Annals of Surgery, vol.238, issue.5, pp.641-649, 2003. ,
DOI : 10.1097/01.sla.0000094387.50865.23
Effect of salt and water balance on recovery of gastrointestinal function after elective colonic resection: a randomised controlled trial, The Lancet, vol.359, issue.9320, pp.1812-1820, 2002. ,
DOI : 10.1016/S0140-6736(02)08711-1
Health-Related Quality of Life and Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy, Current Problems in Cancer, vol.33, issue.3, pp.203-221, 2009. ,
DOI : 10.1016/j.currproblcancer.2009.06.008
Early and long-term postoperative management following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, World Journal of Gastrointestinal Oncology, vol.2, issue.1, pp.36-43, 2010. ,
DOI : 10.4251/wjgo.v2.i1.36
Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, Anaesthesia, vol.61, issue.4, pp.389-95, 2008. ,
DOI : 10.1245/ASO.2003.03.067
A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei, Annals of Surgical Oncology, vol.93, issue.2, pp.484-92, 2007. ,
DOI : 10.1245/s10434-006-9182-x
Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC), World Journal of Surgical Oncology, vol.9, issue.1, p.169, 2011. ,
DOI : 10.1016/j.ejso.2005.08.009
Complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: Risk factors for ICU admission and morbidity prognostic score, Surgical Oncology, vol.25, issue.1, pp.6-15, 2016. ,
DOI : 10.1016/j.suronc.2015.11.003
Impact of Hospital Volume on Operative Mortality for Major Cancer Surgery, JAMA, vol.280, issue.20, pp.1747-51, 1998. ,
DOI : 10.1001/jama.280.20.1747
Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies, Annals of Surgery, vol.255, issue.2, pp.348-56, 2012. ,
DOI : 10.1097/SLA.0b013e3182436c28
Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy???A Journey to Becoming a Nationally Funded Peritonectomy Center, Annals of Surgical Oncology, vol.15, issue.8, pp.2270-80, 2007. ,
DOI : 10.1245/s10434-007-9406-8
Impact of surgical volume of centers on post-operative outcomes from cytoreductive surgery and hyperthermic intra-peritoneal chemoperfusion, J Gastrointest Oncol. Feb, vol.7, issue.1, pp.122-130, 2016. ,
Selection of patients and staging of peritoneal surface malignancies, World Journal of Gastrointestinal Oncology, vol.2, issue.1, pp.31-36, 2010. ,
DOI : 10.4251/wjgo.v2.i1.31
Depressive Symptoms in Patients Scheduled for Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery: Prospective Associations With Morbidity and Mortality, Journal of Clinical Oncology, vol.34, issue.11, pp.1217-1239, 2016. ,
DOI : 10.1200/JCO.2015.62.9683
Peritoneal Surface Disease Severity Score as a predictor of resectability in the treatment of peritoneal surface malignancies, The American Journal of Surgery, vol.207, issue.3, 2014. ,
DOI : 10.1016/j.amjsurg.2013.09.021
The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis, Annals of Surgical Oncology, vol.21, issue.13, pp.4195-201, 2014. ,
DOI : 10.1245/s10434-014-3798-z
Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis, Journal of Surgical Oncology, vol.10, issue.1, pp.9-15, 2009. ,
DOI : 10.1002/jso.21169
Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis, International Journal of Surgical Oncology, vol.2016, p.2495131, 2016. ,
DOI : 10.1245/s10434-014-4041-7
The relationship between baseline nutritional status with subsequent parenteral nutrition and clinical outcomes in cancer patients undergoing hyperthermic intraperitoneal chemotherapy, Nutrition Journal, vol.12, issue.1, p.118, 2013. ,
DOI : 10.1097/01.ccx.0000235204.54579.14
Evaluating the Impact of Total Intravenous Anesthesia on the Clinical Outcomes and Perioperative NLR and PLR Profiles of Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Annals of Surgical Oncology, vol.20, issue.Suppl 3, 2016. ,
DOI : 10.1245/s10434-016-5176-5
A Randomized Trial of Goal Directed vs Standard Fluid Therapy in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Journal of Gastrointestinal Surgery, vol.110, issue.4, 2015. ,
DOI : 10.1007/s11605-015-2743-1
Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients, Gastroenterology Research and Practice, vol.55, issue.86-87, p.635314, 2012. ,
DOI : 10.1016/j.ejso.2004.09.011
Peri-operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy, Anaesthesia, vol.61, issue.4, pp.389-95, 2008. ,
DOI : 10.1245/ASO.2003.03.067
Epidural analgesia for surgical treatment of peritoneal carcinomatosis: a risky technique?]. Ann Françaises Anesthèsie Rèanimation, pp.53-62, 2012. ,
Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement, Annals of Surgical Oncology, vol.2014, issue.1, pp.1486-95, 2016. ,
DOI : 10.1245/s10434-015-4963-8
Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?, Journal of Oncology, vol.84, issue.1, p.307317, 2014. ,
DOI : 10.1016/j.jamcollsurg.2006.12.048
Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery, Cochrane Database Syst Rev, vol.10, p.10356, 2015. ,